Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy With Nanoliposomal Irinotecan in Patients With Peritoneal Surface Malignancies

NCT04088786 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.

NCT NCT04088786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04088786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy With Nanoliposomal Irinotecan in Patients With Peritoneal Surface Malignancies
Lead sponsor
Stony Brook University
Phase
Phase 1
Overall status
Completed
Start date
October 22, 2019
Completion date
April 14, 2022
Enrollment
18 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, gastric cancer, mesothelioma, mucinous adenocarcinoma, mucinous tumor, peritoneal cancer, primary peritoneal carcinoma, pseudomyxoma peritonei